Award recordCONTRACT

ACCREDO HEALTH GROUP, INC

PIID 36C26120P0754· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $93,342 net obligations· UEI LERPSGUE3528· TN

Description

TYVASO

First action · last action
2020-03-21 · 2021-04-20
Transactions
3
First transaction's obligation
$92,768
Base + all options value (sum of deltas)
$93,342
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
AUTHORIZED RESALE (FAR 6.302-5(A)(2)(II))
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$93,343$0Base award · 2020-03-21 · this action $92,768 · running total $92,768Modification P00001 · 2020-09-30 · this action $576 · running total $93,343Modification P00003 · 2021-04-20 · this action -$1 · running total $93,342
  • Base2020-03-21+$92,768= $92,768
  • Mod P000012020-09-30+$576= $93,343
  • Mod P000032021-04-20-$1= $93,342
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-03-21+$92,768$92,768TYVASO
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-09-30+$576$93,343TYVASO
Mod P00003· CLOSE OUT2021-04-20−$1$93,342TYVASO

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI LERPSGUE3528)

AwardOffice · PSC / listingNet obligationsFY
36C25226P0445252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$349,099FY2026
36C25926P0120NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$11,198FY2026
36C25925P1097NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$11,198FY2025
36C24225P1342242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$17,490FY2025
36C24225P1200242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$10,122FY2025
36C26025P0979260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$13,364FY2025

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26120P0754_3600_-NONE-_-NONE- · retrieved 2026-09-26.